Skip to main content
SpringerLink
Log in

Vascular Calcification: Pathophysiology and Risk Factors

  • CARDIOVASCULAR RISK AND HYPERTENSION (PW de LEEUW AND AH GRADMAN, SECTION EDITORS)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Vascular calcification can occur in nearly all arterial beds and in both the medial and intimal layers. The initiating factors and clinical consequences depend on the underlying disease state and location of the calcification. The best studied manifestation is coronary artery calcification, in part because of the obvious clinical consequences, but also because of CT-based imaging modalities. In the general population, the presence of coronary artery calcification increases cardiovascular risk above that predicted by traditional Framingham risk factors, suggesting the presence of nontraditional risk factors. In patients with chronic kidney disease (CKD), coronary artery calcification is more prevalent and markedly more severe than in the general population. In these CKD patients, nontraditional risk factors such as oxidative stress, advanced glycation end products, and disordered mineral metabolism are also more prevalent and more severe and offer mechanistic insight into the pathogenesis of vascular calcification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2008;19(2):213–6.

    Article  PubMed  CAS  Google Scholar 

  2. Ibanez B, Badimon JJ, Garcia MJ. Diagnosis of atherosclerosis by imaging. Am J Med. 2009;122(1 Suppl):S15–25.

    Article  PubMed  Google Scholar 

  3. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004;95(6):560–7.

    Article  PubMed  CAS  Google Scholar 

  4. Proudfoot D, Shanahan CM, Weissberg PL. Vascular calcification: new insights into an old problem [editorial; comment]. J Pathol. 1998;185(1):1–3.

    Article  PubMed  CAS  Google Scholar 

  5. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16(8):978–83.

    Article  PubMed  CAS  Google Scholar 

  6. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731–40.

    Article  PubMed  Google Scholar 

  7. Moe SM, Chen NX. Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol. 2003;18:969–75.

    Article  PubMed  Google Scholar 

  8. Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol. 2008;52(1):17–23.

    Article  PubMed  Google Scholar 

  9. Block, G.A., P. Raggi, A. Bellasi, L. Kooienga, and D.M. Spiegel, Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int, 2007.

  10. Mehrotra R, Budoff M, Hokanson JE, Ipp E, Takasu J, Adler S. Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int. 2005;68(3):1258–66.

    Article  PubMed  Google Scholar 

  11. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68(4):1815–24.

    Article  PubMed  CAS  Google Scholar 

  12. Moe SM, O'Neill KD, Reslerova M, Fineberg N, Persohn S, Meyer CA. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant. 2004;19(9):2387–93.

    Article  PubMed  Google Scholar 

  13. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrology, Dialysis, Transplantation. 2000;15(2):218–23.

    Article  PubMed  CAS  Google Scholar 

  14. Gross ML, Meyer HP, Ziebart H, Rieger P, Wenzel U, Amann K, et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol. 2007;2(1):121–34.

    Article  PubMed  Google Scholar 

  15. Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol. 2009;4(12):1892–900.

    Article  PubMed  CAS  Google Scholar 

  16. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002;61(2):638–47.

    Article  PubMed  Google Scholar 

  17. Allison MA, Hsi S, Wassel CL, Morgan C, Ix JH, Wright CM, et al. Calcified atherosclerosis in different vascular beds and the risk of mortality. Arterioscler Thromb Vasc Biol. 2012;32(1):140–6.

    Article  PubMed  CAS  Google Scholar 

  18. Chen NX, O'Neill KD, Chen X, Moe SM. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res. 2008;23(11):1798–805.

    Article  PubMed  CAS  Google Scholar 

  19. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008;118(17):1748–57.

    Article  PubMed  CAS  Google Scholar 

  20. •• Chen, N.X., F. Kircelli, K.D. O'Neill, X. Chen, and S.M. Moe, Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int, 2010. 77(5): p. 436-42. This study provides evidence of the importance of extracellular calcium in MV activity and calcification.

    Article  PubMed  CAS  Google Scholar 

  21. Barreto DV, Barreto Fde C, Carvalho AB, Cuppari L, Draibe SA, Dalboni MA, et al. Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am J Kidney Dis. 2008;52(6):1139–50.

    Article  PubMed  CAS  Google Scholar 

  22. Ketteler M, Biggar PH. Review article: getting the balance right: assessing causes and extent of vascular calcification in chronic kidney disease. Nephrology (Carlton). 2009;14(4):389–94.

    Article  CAS  Google Scholar 

  23. Everhart JE, Pettitt DJ, Knowler WC, Rose FA, Bennett PH. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia. 1988;31(1):16–23.

    PubMed  CAS  Google Scholar 

  24. Mehrotra R, Budoff M, Christenson P, Ipp E, Takasu J, Gupta A, et al. Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int. 2004;66(5):2022–31.

    Article  PubMed  Google Scholar 

  25. Chertow, G.M., P. Raggi, S. Chasan-Taber, J. Bommer, H. Holzer, and S.K. Burke, Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant, 2004.

  26. Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis. 2009;202(1):289–95.

    Article  PubMed  CAS  Google Scholar 

  27. Henein MY, Owen A. Statins moderate coronary stenoses but not coronary calcification: results from meta-analyses. Int J Cardiol. 2011;153(1):31–5.

    Article  PubMed  Google Scholar 

  28. Raggi P, Cooil B, Callister TQ. Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J. 2001;141(3):375–82.

    Article  PubMed  CAS  Google Scholar 

  29. Budoff MJ, Rader DJ, Reilly MP, Mohler 3rd ER, Lash J, Yang W, et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2011;58(4):519–26.

    Article  PubMed  Google Scholar 

  30. Detrano R. The ethnic-specific nature of mechanisms for coronary heart disease. J Am Coll Cardiol. 2003;41(1):45–6.

    Article  PubMed  Google Scholar 

  31. Elias-Smale SE, Proenca RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol. 2010;56(17):1407–14.

    Article  PubMed  Google Scholar 

  32. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291(2):210–5.

    Article  PubMed  CAS  Google Scholar 

  33. Kalsch H, Lehmann N, Mohlenkamp S, Neumann T, Slomiany U, Schmermund A, et al. Association of coronary artery calcium and congestive heart failure in the general population: results of the Heinz Nixdorf Recall study. Clin Res Cardiol. 2010;99(3):175–82.

    Article  PubMed  CAS  Google Scholar 

  34. •• Peters, S.A., M. Bakker, H.M. den Ruijter, and M.L. Bots, Added value of CAC in risk stratification for cardiovascular events: a systematic review. Eur J Clin Invest, 2012. 42(1): p. 110-6. This systemic review provides important information regarding the risk factors for coronary artery calcification.

    Article  PubMed  Google Scholar 

  35. •• Savoia, C., D. Burger, N. Nishigaki, A. Montezano, and R.M. Touyz, Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med, 2011. 13: p. e11. This review describes the roles of renin-angiotensin systems in VSMC growth, apoptosis, differentiation, and calcification.

  36. • Armstrong, Z.B., D.R. Boughner, M. Drangova, and K.A. Rogers, Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model. Cardiovasc Res, 2011. 90(1): p. 165-70. This article provides evidence regarding the angiotensin receptor in the development of arterial calcification.

    Article  PubMed  CAS  Google Scholar 

  37. Tokumoto M, Mizobuchi M, Finch JL, Nakamura H, Martin DR, Slatopolsky E. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification. Am J Nephrol. 2009;29(6):582–91.

    Article  PubMed  CAS  Google Scholar 

  38. Wu SY, Yu YR, Cai Y, Jia LX, Wang X, Xiao CS, et al. Endogenous aldosterone is involved in vascular calcification in rat. Exp Biol Med (Maywood). 2012;237(1):31–7.

    Article  CAS  Google Scholar 

  39. Chen NX, Duan D, O'Neill D. K, and S.M. Moe, High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant. 2006;21(12):3435–42.

    Article  PubMed  CAS  Google Scholar 

  40. Al-Aly Z, Shao JS, Lai CF, Huang E, Cai J, Behrmann A, et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol. 2007;27(12):2589–96.

    Article  PubMed  CAS  Google Scholar 

  41. Bostrom KI, Jumabay M, Matveyenko A, Nicholas SB, Yao Y. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res. 2011;108(4):446–57.

    Article  PubMed  Google Scholar 

  42. Parhami F, Basseri B, Hwang J, Tintut Y, Demer LL. High-density lipoprotein regulates calcification of vascular cells. Circ Res. 2002;91(7):570–6.

    Article  PubMed  CAS  Google Scholar 

  43. • Ting, T.C., S. Miyazaki-Anzai, M. Masuda, M. Levi, L.L. Demer, Y. Tintut, and M. Miyazaki, Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J Biol Chem, 2011. 286(27): p. 23938-49. This article provides evidence for lipid metabolism and lipogenesis as risk factors for vascular calcification.

    Article  PubMed  CAS  Google Scholar 

  44. Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y. N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. Circ Res. 2006;98(6):727–9.

    Article  PubMed  CAS  Google Scholar 

  45. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997;17(4):680–7.

    Article  PubMed  CAS  Google Scholar 

  46. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363–9.

    Article  PubMed  Google Scholar 

  47. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, et al. Immunologic function and survival in hemodialysis patients. Kidney Int. 1998;54(1):236–44.

    Article  PubMed  CAS  Google Scholar 

  48. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106(1):100–5.

    Article  PubMed  Google Scholar 

  49. Stompor T, Krasniak A, Sulowicz W, Dembinska-Kiec A, Janda K, Wojcik K, et al. Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant. 2005;20(2):404–12.

    Article  PubMed  Google Scholar 

  50. Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation. 2007;116(24):2841–50.

    Article  PubMed  CAS  Google Scholar 

  51. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102(21):2636–42.

    PubMed  CAS  Google Scholar 

  52. Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 2002;105(5):650–5.

    Article  PubMed  CAS  Google Scholar 

  53. Okazaki H, Shioi A, Hirowatari K, Koyama H, Fukumoto S, Ishimura E, et al. Phosphatidylinositol 3-kinase/Akt pathway regulates inflammatory mediators-induced calcification of human vascular smooth muscle cells. Osaka City Med J. 2009;55(2):71–80.

    PubMed  CAS  Google Scholar 

  54. Amore A, Coppo R. Immunological basis of inflammation in dialysis. Nephrol Dial Transplant. 2002;17 Suppl 8:16–24.

    Article  PubMed  CAS  Google Scholar 

  55. Zoccali C, Mallamaci F, Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol. 2004;15 Suppl 1:S77–80.

    Article  PubMed  Google Scholar 

  56. • Yamada, S., M. Taniguchi, M. Tokumoto, J. Toyonaga, K. Fujisaki, T. Suehiro, H. Noguchi, M. Iida, K. Tsuruya, and T. Kitazono, The antioxidant tempol ameliorates arterial medial calcification in uremic rats: Important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res, 2011. This study demonstrated that oxidative stress induced by uremia may play a role in the development of vascular calcification in CKD.

  57. Sutra T, Morena M, Bargnoux AS, Caporiccio B, Canaud B, Cristol JP. Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media. Free Radic Res. 2008;42(9):789–97.

    Article  PubMed  CAS  Google Scholar 

  58. Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak Jr J, Pomerantzeff PM, et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2008;28(3):463–70.

    Article  PubMed  CAS  Google Scholar 

  59. You H, Yang H, Zhu Q, Li M, Xue J, Gu Y, et al. Advanced oxidation protein products induce vascular calcification by promoting osteoblastic trans-differentiation of smooth muscle cells via oxidative stress and ERK pathway. Ren Fail. 2009;31(4):313–9.

    Article  PubMed  CAS  Google Scholar 

  60. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008;283(22):15319–27.

    Article  PubMed  CAS  Google Scholar 

  61. Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem. 2002;277(16):14221–6.

    Article  PubMed  CAS  Google Scholar 

  62. Tseng W, Lu J, Bishop GA, Watson AD, Sage AP, Demer L, et al. Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids. J Lipid Res. 2010;51(5):1010–6.

    Article  PubMed  CAS  Google Scholar 

  63. Demer LL. Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol. 2002;31(4):737–41.

    Article  PubMed  Google Scholar 

  64. Niwa T, Katsuzaki T, Miyazaki S, Miyazaki T, Ishizaki Y, Hayase F, et al. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest. 1997;99(6):1272–80.

    Article  PubMed  CAS  Google Scholar 

  65. Miyata T, Sprague SM. Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis. Nephrol, Dial, Transplant. 1996;11 Suppl 3:86–90.

    Article  CAS  Google Scholar 

  66. Sakata N, Noma A, Yamamoto Y, Okamoto K, Meng J, Takebayashi S, et al. Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant. 2003;18(8):1601–9.

    Article  PubMed  CAS  Google Scholar 

  67. Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H. Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun. 1999;258(2):353–7.

    Article  PubMed  CAS  Google Scholar 

  68. Tanikawa T, Okada Y, Tanikawa R, Tanaka Y. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res. 2009;46(6):572–80.

    Article  PubMed  CAS  Google Scholar 

  69. Naka Y, Bucciarelli LG, Wendt T, Lee LK, Rong LL, Ramasamy R, et al. RAGE axis: Animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol. 2004;24(8):1342–9.

    Article  PubMed  CAS  Google Scholar 

  70. Ren X, Shao H, Wei Q, Sun Z, Liu N. Advanced glycation end-products enhance calcification in vascular smooth muscle cells. J Int Med Res. 2009;37(3):847–54.

    PubMed  CAS  Google Scholar 

  71. Suga T, Iso T, Shimizu T, Tanaka T, Yamagishi S, Takeuchi M, et al. Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. J Atheroscler Thromb. 2011;18(8):670–83.

    Article  PubMed  CAS  Google Scholar 

  72. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607–17.

    Article  PubMed  CAS  Google Scholar 

  73. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478–83.

    Article  PubMed  CAS  Google Scholar 

  74. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62(1):245–52.

    Article  PubMed  CAS  Google Scholar 

  75. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112(17):2627–33.

    Article  PubMed  CAS  Google Scholar 

  76. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87(7):E10–7.

    PubMed  CAS  Google Scholar 

  77. Jono S, Peinado C, Giachelli CM. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem. 2000;275(26):20197–203.

    Article  PubMed  CAS  Google Scholar 

  78. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001;89(12):1147–54.

    Article  PubMed  CAS  Google Scholar 

  79. Werner A, Dehmelt L, Nalbant P. Na +-dependent phosphate cotransporters: the NaPi protein families. J Exp Biol. 1998;201(Pt 23):3135–42.

    PubMed  CAS  Google Scholar 

  80. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res. 2006;98(7):905–12.

    Article  PubMed  CAS  Google Scholar 

  81. Chen NX, O'Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62(5):1724–31.

    Article  PubMed  CAS  Google Scholar 

  82. Chen, N.X., D. Duan, D. O'Neill K, G.O. Wolisi, J.J. Koczman, R. Laclair, and S.M. Moe, The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells. Kidney Int, 2006.

  83. Hosaka N, Mizobuchi M, Ogata H, Kumata C, Kondo F, Koiwa F, et al. Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells. Calcif Tissue Int. 2009;85(6):523–9.

    Article  PubMed  CAS  Google Scholar 

  84. Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun. 2005;334(2):524–32.

    Article  PubMed  CAS  Google Scholar 

  85. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol. 2000;20(23):8783–92.

    Article  PubMed  CAS  Google Scholar 

  86. Bouvet C, Moreau S, Blanchette J, de Blois D, Moreau P. Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol. 2008;28(5):856–62.

    Article  PubMed  CAS  Google Scholar 

  87. • Chen, N.X., Kalisha D. O’Neill, Xianming Chen Kiattisunthorn, Kraiwporn, Vincent H. Gattone and Sharon M. Moe, Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. American Journal of Nephrology, 2011. Vol. 34(No. 3). This study suggests that matrix degradation plays an important role in vascular calcification in CKD.

  88. Moe SM, Chertow GM. The Case against Calcium-Based Phosphate Binders. Clin J Am Soc Nephrol. 2006;1(4):697–703.

    Article  PubMed  CAS  Google Scholar 

  89. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int. 2004;66(6):2293–9.

    Article  PubMed  CAS  Google Scholar 

  90. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15(11):2857–67.

    Article  PubMed  CAS  Google Scholar 

  91. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol. 2004;15(6):1392–401.

    Article  PubMed  CAS  Google Scholar 

  92. • Shroff, R.C., R. McNair, J.N. Skepper, N. Figg, L.J. Schurgers, J. Deanfield, L. Rees, and C.M. Shanahan, Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol, 2010. 21(1): p. 103-12. This study demonstrates an important role for calcium in VSMC calcification.

    Article  PubMed  CAS  Google Scholar 

  93. Kapustin AN, Davies JD, Reynolds JL, McNair R, Jones GT, Sidibe A, et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res. 2011;109(1):e1–e12.

    Article  PubMed  CAS  Google Scholar 

  94. Wolf M. Fibroblast growth factor 23 and the future of phosphorus management. Curr Opin Nephrol Hypertens. 2009;18(6):463–8.

    Article  PubMed  CAS  Google Scholar 

  95. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45–51.

    Article  PubMed  CAS  Google Scholar 

  96. Balci M, Kirkpantur A, Gulbay M, Gurbuz OA. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Hemodial Int. 2010;14(4):425–32.

    Article  PubMed  Google Scholar 

  97. •Desjardins, L., S. Liabeuf, C. Renard, A. Lenglet, H.D. Lemke, G. Choukroun, T.B. Drueke, and Z.A. Massy, FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int, 2011. This study demonstrates an important role for FGF23 in vascular calcification in CKD.

  98. Stubbs J, Liu S, Quarles LD. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial. 2007;20(4):302–8.

    Article  PubMed  Google Scholar 

  99. El-Abbadi MM, Pai AS, Leaf EM, Yang HY, Bartley BA, Quan KK, et al. Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int. 2009;75(12):1297–307.

    Article  PubMed  CAS  Google Scholar 

  100. Takei, Y., H. Yamamoto, T. Sato, A. Otani, M. Kozai, M. Masuda, Y. Taketani, K. Muto-Sato, B. Lanske, and E. Takeda, Stanniocalcin 2 is associated with ectopic calcification in alpha-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells. Bone, 2012.

Download references

Disclosure

Dr. Chen has received grant support from Genzyme Corp. and has received royalties from Amgen.

Dr. Moe has served as a consultant for and received honoraria from Genzyme Corp., Shire, Amgen, and Citrolink; has been paid for providing expert testimony by Fitzpatrick; has received grant support from Genzyme Corp., Shire, and Amgen; holds stock/stock options in Eli Lilly and Company; and has had travel/accommodations expenses covered/reimbursed by Shire, Genzyme Corp., and Amgen.

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, Indiana University School of Medicine, 950 West Walnut Street, R2-Room 219, Indianapolis, IN, 46202, USA

    Neal X. Chen

  2. Division of Nephrology, Department of Medicine, Indiana University School of Medicine, 950 West Walnut Street, R2-Room E202C; Roudebush Veterans Affairs Medical Center, 1481 West 10th Street, Indianapolis, IN, 46202, USA

    Sharon M. Moe

Authors
  1. Neal X. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon M. Moe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neal X. Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, N.X., Moe, S.M. Vascular Calcification: Pathophysiology and Risk Factors. Curr Hypertens Rep 14, 228–237 (2012). https://doi.org/10.1007/s11906-012-0265-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-012-0265-8

Keywords

Search

Navigation